Published in Circulation on August 28, 2001
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol (2009) 6.41
Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson (2014) 1.26
5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J Virol (2005) 1.19
The importance of cardiac MRI as a diagnostic tool in viral myocarditis-induced cardiomyopathy. Neth Heart J (2009) 1.14
Outcome of acute fulminant myocarditis in children. Heart (2006) 1.10
Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis. Heart Fail Rev (2013) 1.07
Cardiac troponin T: a marker in the diagnosis of acute myocarditis in children. Pediatr Cardiol (2005) 1.03
Idiopathic acute myocarditis during treatment for controlled human malaria infection: a case report. Malar J (2014) 1.00
Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies. BMC Mol Biol (2008) 1.00
Myocarditis: infection versus autoimmunity. J Clin Immunol (2009) 0.98
Rotavirus and coxsackievirus infection activated different profiles of toll-like receptors and chemokines in intestinal epithelial cells. Inflamm Res (2009) 0.93
Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart (2004) 0.93
Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis. Future Virol (2012) 0.93
Increased expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditis. Virol J (2012) 0.92
Coagulation, protease-activated receptors, and viral myocarditis. J Cardiovasc Transl Res (2013) 0.91
Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy. J Card Fail (2008) 0.89
Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Arch Dis Child (2004) 0.89
Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis. Eur Heart J Cardiovasc Imaging (2015) 0.87
Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection. Future Microbiol (2011) 0.87
NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy. PLoS One (2008) 0.86
Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system. Heart Fail Rev (2004) 0.85
Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism. Med Microbiol Immunol (2003) 0.85
Correlation between virus persistent infection and cardic function in patients with dilated cardiomyopathy. J Zhejiang Univ Sci B (2013) 0.82
Clinical outcome of acute myocarditis in children according to treatment modalities. Korean J Pediatr (2010) 0.81
Chemical mutagenesis: a new strategy against the global threat of infectious diseases. Mamm Genome (2008) 0.81
Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis. Am J Pathol (2009) 0.81
Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy. Stem Cells Int (2013) 0.80
Antiviral effects of interferon-β are enhanced in the absence of the translational suppressor 4E-BP1 in myocarditis induced by Coxsackievirus B3. Antivir Ther (2011) 0.80
Role of endomyocardial biopsy for children presenting with acute systolic heart failure. Pediatr Cardiol (2013) 0.80
B-cell epitope spreading is a critical step for the switch from C-protein-induced myocarditis to dilated cardiomyopathy. Am J Pathol (2007) 0.79
Immunopathogenesis of dilated cardiomyopathy. Evidence for the role of TH2-type CD4+T lymphocytes and association with myocardial HLA-DR expression. J Clin Immunol (2006) 0.79
Cardiac cell-specific apoptotic and cytokine responses to reovirus infection: determinants of myocarditic phenotype. J Card Fail (2009) 0.79
Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis. Circ Cardiovasc Genet (2014) 0.79
Comprehensive Cardiac Magnetic Resonance for Short-Term Follow-Up in Acute Myocarditis. J Am Heart Assoc (2016) 0.78
Local experience with extracorporeal membrane oxygenation in children with acute fulminant myocarditis. PLoS One (2013) 0.78
Detection of clonal T-cell-receptor (TCR) Vbeta rearrangements in explanted dilated cardiomyopathy hearts by semi-nested PCR, GeneScan, and direct sequencing. Med Sci Monit Basic Res (2013) 0.77
Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study. Rheumatology (Oxford) (2009) 0.77
Cacao polyphenols ameliorate autoimmune myocarditis in mice. Hypertens Res (2015) 0.76
New echocardiographic findings correlate with intramyocardial inflammation in endomyocardial biopsies of patients with acute myocarditis and inflammatory cardiomyopathy. Mediators Inflamm (2013) 0.76
Distinct kinetics of viral replication, T cell infiltration, and fibrosis in three phases of myocarditis following Theiler's virus infection. Cell Immunol (2015) 0.76
[Not Available]. Neth Heart J (2011) 0.75
Incremental value of PET and MRI in the evaluation of cardiovascular abnormalities. Insights Imaging (2016) 0.75
CMR in Heart Failure. Cardiol Res Pract (2011) 0.75
Cardiac migration of endogenous mesenchymal stromal cells in patients with inflammatory cardiomyopathy. Mediators Inflamm (2015) 0.75
Pathophysiological role of autoantibodies against G-protein-coupled receptors in the cardiovascular system. Exp Clin Cardiol (2005) 0.75
Results of comprehensive diagnostic work-up in 'idiopathic' dilated cardiomyopathy. Open Heart (2015) 0.75
Effect and Mechanism of QiShenYiQi Pill on Experimental Autoimmune Myocarditis Rats. Med Sci Monit (2016) 0.75
IL-9 Inhibits Viral Replication in Coxsackievirus B3-Induced Myocarditis. Front Immunol (2016) 0.75
Amyocarditic coxsackievirus B3 causes myocarditis in immunocompromised mice. Exp Clin Cardiol (2003) 0.75
Immune suppressive treatment in paediatric myocarditis: still awaiting the evidence. Heart (2004) 0.75
L-arginine ameliorates experimental autoimmune myocarditis by maintaining extracellular matrix and reducing cytotoxic activity of lymphocytes. Int J Exp Pathol (2008) 0.75
Organ-specific protective role of NKT cells in virus-induced inflammatory demyelination and myocarditis depends on mouse strain. J Neuroimmunol (2014) 0.75
Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis. Heart Rhythm (2015) 0.75
Lights and shadows of cardiac magnetic resonance imaging in acute myocarditis. Insights Imaging (2015) 0.75
Coxsackievirus B3 Directly Induced Th17 Cell Differentiation by Inhibiting Nup98 Expression in Patients with Acute Viral Myocarditis. Front Cell Infect Microbiol (2016) 0.75
Feature-tracking myocardial strain analysis in acute myocarditis: diagnostic value and association with myocardial oedema. Eur Radiol (2017) 0.75
Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy. Clin Res Cardiol (2016) 0.75
Acrasin, Acrasinase, and the sensitivity to acrasin in Dictyostelium discoideum. Dev Biol (1969) 3.56
Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep (1978) 2.63
Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am J Psychiatry (1995) 2.39
Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. Circulation (1983) 2.24
Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol (1980) 2.17
Interaction of plasma kallikrein with the C1 inhibitor. J Immunol (1970) 2.07
Amiodarone. N Engl J Med (1987) 2.05
Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation (1996) 1.86
Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation (1997) 1.84
Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med (1983) 1.81
Deficits in short-term memory in posttraumatic stress disorder. Am J Psychiatry (1993) 1.81
Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep (1978) 1.68
Techniques for right and left ventricular endomyocardial biopsy. Am J Cardiol (1978) 1.68
A review of psychoendocrine research on the pituitary-adrenal cortical system. Psychosom Med (1969) 1.65
Early anthracycline cardiotoxicity. Am J Med (1978) 1.63
Low urinary cortisol excretion in patients with posttraumatic stress disorder. J Nerv Ment Dis (1990) 1.63
Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry (1993) 1.56
Plasma kallikrein and Hageman factor in Gram-negative bacteremia. Ann Intern Med (1970) 1.53
Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry (1991) 1.52
Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Electrophysiologic Study Versus Electromagnetic Monitoring. Circulation (1997) 1.49
The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states. Ann Intern Med (1969) 1.45
Multiple hormonal responses to graded exercise in relation to physical training. J Appl Physiol (1972) 1.42
Inhibition of insulin secretion by infused epinephrine in rhesus monkeys. Endocrinology (1966) 1.39
Urinary free-cortisol levels in posttraumatic stress disorder patients. J Nerv Ment Dis (1986) 1.35
Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann Intern Med (1978) 1.34
Effects of Physicochemical Factors and Bacterial Colony Morphotype on Association of Vibrio vulnificus with Hemocytes of Crassostrea virginica. Appl Environ Microbiol (1993) 1.32
Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation (1978) 1.28
Malignant ventricular tachyarrhythmias associated with the use of encainide. Am Heart J (1981) 1.27
Multiple hormonal responses to prolonged exercise in relation to physical training. J Appl Physiol (1972) 1.24
Viability of Vibrio vulnificus in Association with Hemocytes of the American Oyster (Crassostrea virginica). Appl Environ Microbiol (1995) 1.23
3'5' AMP and Ca 2+ in slime mold aggregation. Exp Cell Res (1971) 1.18
Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders. Biol Psychiatry (1993) 1.18
Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res (1984) 1.14
Endomyocardial biopsy: the balance of success and failure. Circulation (1985) 1.13
Amiodarone pulmonary toxicity and Professor Hounsfield. J Cardiovasc Electrophysiol (2001) 1.10
Adriamycin cardiotoxicity: endomyocardial biopsy evidence of enhancement by irradiation. Am J Surg Pathol (1977) 1.10
Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy. Cancer Treat Rep (1978) 1.10
A re-evaluation of the concept of "non-specificity" in stress theory. J Psychiatr Res (1971) 1.08
Endomyocardial biopsy. Ann Intern Med (1982) 1.07
Prolongation of the human cardiac monophasic action potential by sotalol. Am J Cardiol (1982) 1.05
Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: a review. Am J Cardiol (1982) 1.05
Autonomic nervous system and arrhythmias: studies in the transplanted denervated human heart. Cardiology (1976) 1.04
Amiodarone blocks inactivated cardiac sodium channels. Pflugers Arch (1983) 1.04
Efficacy and cost of cardiac monitoring in patients receiving doxorubicin. Cancer (1982) 1.04
Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. Am Heart J (1981) 1.04
Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. Am J Cardiol (1987) 1.03
A review of psychoendocrine research on the sympathetic-adrenal medullary system. Psychosom Med (1969) 1.00
Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J Nerv Ment Dis (1992) 0.99
Renin, norepinephrine, and epinephrine responses to graded exercise. J Appl Physiol (1971) 0.99
A psychoendocrine study of bereavement. II. Observations on the process of mourning in relation to adrenocortical function. Psychosom Med (1973) 0.96
A historical view of the stress field. J Human Stress (1975) 0.95
Cardiac sarcoidosis. Diagnosis with endomyocardial biopsy and treatment with corticosteroids. Am J Cardiol (1978) 0.95
Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder. Psychoneuroendocrinology (1987) 0.94
Surgery for ventricular tachycardia: efficacy of left ventricular aneurysm resection compared with operation guided by electrical activation mapping. Circulation (1982) 0.94
Inflammatory myocardial diseases and cardiomyopathies. Am J Med (1997) 0.93
Infections after cardiac transplantation: relation to rejection therapy. Ann Intern Med (1976) 0.93
The Myocarditis Treatment Trial: design, methods and patients enrollment. Eur Heart J (1995) 0.92
Electrophysiologic findings in patients with idiopathic hypertrophic subaortic stenosis. Am J Cardiol (1978) 0.92
Effects of acute tryptophan depletion on nocturnal melatonin secretion in humans. J Clin Endocrinol Metab (1993) 0.91
Strategy in psychosomatic research. Psychosom Med (1971) 0.91
Clinical electrophysiologic effects of tocainide. Circulation (1978) 0.91
Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. The ESVEM Investigators. Am Heart J (1999) 0.90
Psychological state and body size as determinants of 17-OHCS excretion. Arch Intern Med (1968) 0.90
Electrophysiological effects of acebutolol. Br Heart J (1978) 0.90
Bacterial endocarditis after cardiac catheterization. Chest (1976) 0.90
Clinical predictors of arrhythmia inducibility in survivors of cardiac arrest: importance of gender and prior myocardial infarction. J Am Coll Cardiol (1988) 0.89
Technetium-99m pyrophosphate myocardial uptake in patients with stable angina pectoris. Am J Cardiol (1977) 0.88
17-OHCS levels in combat. Special forces "A" team under threat of attack. Arch Gen Psychiatry (1968) 0.88
Pharmacokinetics and regional electrophysiological effects of intracoronary amiodarone administration. Circulation (1995) 0.88
Clinical electrophysiologic effects of encainide, a newly developed antiarrhythmic agent. Am J Cardiol (1979) 0.88
A historical view of the stress field. J Human Stress (1975) 0.87
Facilitation of ventricular tachyarrhythmia induction by isoproterenol. Am J Cardiol (1984) 0.86
Renin, noradrenaline and adrenaline responses to simulated altitude. Clin Sci (1973) 0.86
A psychoendocrine study of bereavement. I. 17-Hydroxycorticosteroid excretion rates of parents following death of their children from leukemia. Psychosom Med (1973) 0.86
Role of cardiac biopsy in the diagnosis and management of cardiac disease. Prog Cardiovasc Dis (1984) 0.86
Heart transplant rejection monitored by signal-averaged electrocardiography in patients receiving cyclosporine. Circulation (1984) 0.86
Bereavement and catecholamines. J Psychosom Res (1986) 0.86
Screening of common bacteria capable of demethylation of methylmercuric chloride. Bull Environ Contam Toxicol (1979) 0.85
Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia. Am J Cardiol (1983) 0.85
Sex differences in prolactin change during mourning. J Psychosom Res (1987) 0.85
Intracardiac electrophysiologic study of intravenous diltiazem and combined diltiazem-digoxin in patients. Am Heart J (1982) 0.85
Recurrent ventricular tachycardia induced by an atrial synchronous ventricular-inhibited pacemaker. Pacing Clin Electrophysiol (1982) 0.85
Signal-averaged electrocardiographic late potentials in patients with ventricular fibrillation or ventricular tachycardia: correlation with clinical arrhythmia and electrophysiologic study. Am J Cardiol (1985) 0.85
Small vessel disease of the heart resulting in myocardial necrosis and death despite angiographically normal coronary arteries. Am J Cardiol (1979) 0.84
The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia, or liver disease. Thromb Diath Haemorrh (1971) 0.84
Accuracy of the ventricular tachycardia-induction study for predicting long-term efficacy and inefficacy of antiarrhythmic drugs. N Engl J Med (1980) 0.83
Haemodynamic effects of acebutolol. Br Heart J (1978) 0.83
Safety and efficacy of intravenous quinidine. Am J Med (1983) 0.83
Repetitive beating after single ventricular extrastimuli: incidence and prognostic significance in patients with recurrent ventricular tachycardia. Am J Cardiol (1980) 0.83
Cardiac biopsy evidence for a cardiomyopathy associated with symptomatic mitral valve prolapse. Am J Cardiol (1978) 0.82
Vulnerability of patients with obstructive hypertrophic cardiomyopathy to ventricular arrhythmia induction in the operating room. Analysis of 17 patients. Am J Cardiol (1983) 0.82
Overdrive suppression in the transplanted heart: effect of the autonomic nervous system on human sinus node recovery. Circulation (1980) 0.82
Insulin levels in monkey plasma determined by immunoassay. Metabolism (1966) 0.82
Recurrent tachyarrhythmia associated with a bifocal demand pacemaker. Chest (1977) 0.82
Comparison of an implanted abdominal aortic counterpulsation device with the intraaortic balloon pump in a heart failure model. J Am Coll Cardiol (1986) 0.82
Thyroid responses to simulated altitude. J Appl Physiol (1973) 0.82